News

Explore the Latest Advancements and Updates.

Immunexpress to Present Data on SeptiCyte™ at the “Meeting of Experts on Biomarkers to Discriminate Bacterial from Other Infectious Causes of Acute Fever”

Immunexpress Supports World Sepsis Day 2015

Immunexpress to Present Data on the Early Diagnosis of Sepsis with SeptiCyte™ LAB at the Next Generation Diagnostics Summit

Immunexpress to Present Data on Utility of SeptiCyte™ LAB for Diagnosing Sepsis at the Pathology Diagnostics Conference

Immunexpress to Submit Molecular ‘Immune Response’ Sepsis Assay to FDA in May

Immunexpress vying for FDA clearance of its sepsis test

Immunexpress raising $40M; measures immune response to shave sepsis diagnostic time to one hour

Immunexpress Receives Early Stage Commercialisation Support to Further Develop SeptiCyte® PLUS

Immunexpress Secures New EU Patent for Immune Biomarkers for Herpes Virus Infection

Immunexpress Announces New Collaboration with MARS Consortium to Improve Care of Sepsis Patients

Immunexpress Secures U.S. Patent for Immune Biomarkers for Herpes Virus Infection

If you are a member of the media, please contact:

David Schull
Russo Partners, LLC
david.schull@russopartnersllc.com

Maddie Stabinski
Russo Partners, LLC
madeline.stabinski@russopartnersllc.com